THE SAFETY AND EFFICACY OF RIFAPENTINE USED TO TREAT DRUG-SUSCEPTIBLE PULMONARY TUBERCULOSIS
A comparative investigation was conducted to study the safety and efficacy of rifapentine (Rifapex, Lipin Ltd, India) used to treat 65 patients with drug-susceptible pulmonary tuberculosis. A study group of 41 patients took rifapentine thrice weekly; a comparison group of 24 patients received a stan...
Saved in:
| Main Authors: | N. V. Litvinova, T. N. Ivanushkina, L. V. Slogotskaya, D. A. Ivanova, S. E. Borisov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2014-04-01
|
| Series: | Туберкулез и болезни лёгких |
| Subjects: | |
| Online Access: | https://www.tibl-journal.com/jour/article/view/64 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience of using rifapentine in continuation phase of treatment of adult tuberculosis cases
by: T. I. Morozova, et al.
Published: (2019-07-01) -
THE ANTI-TUBERCULOSIS ANTIBIOTIC OF RIFAPENTINE: PERSPECTIVES OF CLINICAL USE
by: A. G. Samoylova, et al.
Published: (2019-01-01) -
Toxicological Evaluation of Intravenous Formulation of Rifapentine
by: K. P. Ostrovskiy, et al.
Published: (2020-05-01) -
Efficacy and safety of a novel short course rifapentine and isoniazid regimen for the preventive treatment of tuberculosis in Chinese silicosis patients: a pilot study (SCRIPT-TB)
by: Qiao-Ling Ruan, et al.
Published: (2025-12-01) -
Rifapex, a New Antituberculosis Agent
by: G. B. Sokolova, et al.
Published: (2020-05-01)